Last Updated:
Access Report
Name Designation Appointment Date Status
Sunil Ashok Inamdar

Appointed as Director since July 2016

 Director 11-Jul-2016 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Mayur Ashok Inamdar

Appointed as Director since July 2016

 Director 11-Jul-2016 Current

People Timeline

Explore the timeline of key personnel in Ojras Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address 702/Narmada, Harijan Vijay Chs St Rd, Bhd Surana Hospital, Little Malbar Hill, , Chembur,, Mumbai Maharashtra, 400071, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 400071
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Ojras Pharmaceuticals Private Limited?
You can contact Ojras Pharmaceuticals Private Limited through their registered address at 702/Narmada, Harijan Vijay Chs St Rd, Bhd Surana Hospital, Little Malbar Hill, , Chembur,, Mumbai Maharashtra, 400071, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Ojras Pharmaceuticals Private Limited?
The current directors of Ojras Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MAYUR ASHOK INAMDAR
  • Sunil Ashok Inamdar
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available